Buscar

01/11/2025 Colonoscopy in symptomatic patients: Validation of AEG-SEED prioritization criteria and added value of FIT. The endoprior study
Rivero-Sánchez, L, Castillo-Iturra, J, Garcia-Rodriguez, A, Zafra, BG, Redondo, PD, Rodriguez, HN, Ponce, M, San Juan, M, Barrera, PB, Seoane, A, Carrasco, MA, Zaffalon, D, Guarner, C, Murzi, M, Jover, R, Medina-Prado, L, Rubio, KA, Matias, DJ, Suárez, BG, Córdova, H, Fernández-Simón, A, Araujo, I, Ginés, A, Pellisé, M, Balaguer, F, Fernández-Esparrach, G. Colonoscopy in symptomatic patients: Validation of AEG-SEED prioritization criteria and added value of FIT. The endoprior study. Gastroenterologia y Hepatologia. 2025; 48(9)DOI:10.1016/j.gastrohep.2025.502471. PMID:40409590. IF:1.900(Q3/7D).
01/11/2025 Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis (vol 83, pg 70, 2025)
Fortea, JI, Alvarado-Tapias, E, Simbrunner, B, Ezcurra, I, Hernández-Gea, V, Aracil, C, Llop, E, Puente, A, Roig, C, Reiberger, T, Garcia-Pagan, JC, Calleja, JL, Ferrero-Gregori, A, Mandorfer, M, Villanueva, C, Crespo, J. Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis (vol 83, pg 70, 2025). JOURNAL OF HEPATOLOGY. 2025; 83(5)DOI:10.1016/j.jhep.2025.08.004. PMID:40914642. IF:33.000(Q1/1D).
18/09/2025 Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases
Valero-Martinez, C, Pardines-Ortiz, M, Montes, N, Dauden, E, Fernández-Gutierrez, B, Garcia-Planella, E, Garcia, FG, Gratacós, J, Perez-Venegas, JJ, Julia, A, Marsal, S, Lamana, A, Garcia-Vicuña, R, González-Alvaro, I, Triguero-Martinez, A. Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(18)DOI:10.3390/ijms26189087. PMID:41009653. IF:4.900(Q1/3D).
01/09/2025 Integration of Artificial Intelligence-Enhanced Capsule Endoscopy in Clinical Practice: A Review of Market-Available Tools for Clinical Practice
Giordano, A, Romero-Mascarell, C, González-Suárez, B, Guarner-Argente, C. Integration of Artificial Intelligence-Enhanced Capsule Endoscopy in Clinical Practice: A Review of Market-Available Tools for Clinical Practice. DIGESTIVE DISEASES AND SCIENCES. 2025; 70(9)DOI:10.1007/s10620-025-09099-4. PMID:40490597. IF:2.500(Q2/5D).
26/07/2025 Role of Tips in Acute Variceal Bleeding
Huerta, A, García-Guix, M, Villanueva, C. Role of Tips in Acute Variceal Bleeding. Current Hepatology Reports. 2025; 24(1)DOI:10.1007/s11901-025-00694-7. PMID:. IF:(Q/D).
01/06/2025 Diagnosis and Management of Early Stages of ALD
Gratacós-Ginés, J, Alvarado-Tapias, E, Martí-Aguado, D, López-Pelayo, H, Bataller, R, Pose, E. Diagnosis and Management of Early Stages of ALD. SEMINARS IN LIVER DISEASE. 2025; 45(02)DOI:10.1055/a-2541-2892. PMID:39965759. IF:3.700(Q2/3D).
12/05/2025 Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry
González-Muñoza, C, Giordano, A, Ricart, E, Nos, P, Iglesias, E, Gisbert, JP, García-López, S, Mesonero, F, Pascual, I, Tardillo, C, Rivero, M, Riestra, S, Mañosa, M, Zabana, Y, Gomollón, F, Calvet, X, García-Sepulcre, MF, Gutiérrez, A, Pérez-Calle, JL, Sierra-Ausín, M, Bermejo, F, Arias, L, Barreiro-de Acosta, M, Barrio, J, Lorente, R, Guardiola, J, Varela, P, Ponferrada-Díaz, A, Marín-Jiménez, I, Pascual, CM, Garcia-Planella, E, Domènech, E. Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry. Journal of Clinical Medicine. 2025; 14(10)DOI:10.3390/jcm14103352. PMID:40429348. IF:2.900(Q1/2D).
01/05/2025 From food to alcohol: Why some patients develop new addictions after bariatric surgery
Alvarado-Tapias, E, Bataller, R, Marti-Aguado, D. From food to alcohol: Why some patients develop new addictions after bariatric surgery. Gastroenterologia y Hepatologia. 2025; 48(5)DOI:10.1016/j.gastrohep.2025.502430. PMID:40107607. IF:1.900(Q3/7D).
01/05/2025 Comparison of Bacterial Infections in Patients With Cirrhosis Between Hospitals With and Without Liver Transplant in Catalonia
Torras, C, Bañares, J, Martí-Carretero, A, Acin, V, Pagès, L, Gutiérrez-Rios, L, Casabella, A, Ferrusquía-Acosta, J, Sánchez-Delgado, J, Pérez, M, Fuertes, D, Garcia-Guix, M, Cuyàs, B, Masnou, H, Amador, A, Soriano, G, Pericàs, JM, Gasch, O, Solé, C. Comparison of Bacterial Infections in Patients With Cirrhosis Between Hospitals With and Without Liver Transplant in Catalonia. LIVER INTERNATIONAL. 2025; 45(5)DOI:10.1111/liv.70076. PMID:40211829. IF:5.200(Q1/2D).
01/05/2025 Evolving epidemiology of HCC in Spain
Sala, M, Pascual, S, Roca, MRR, Matilla, AM, Campos, M, Delgado, M, Ferrer, MT, Montero, JL, Gonzalez-Santiago, JM, Guerrero, A, Aracil, C, Rodriguez-Lopez, C, Romero-Gutierrez, M, Sogbe, M, Vazquez-Rodriguez, S, Olmo, JF, Minguez, B, Cortes-Garcia, L, Vallejo-Senra, N, Unceta, PR, Clos, A, Diaz-Bethencourt, D, Sanchez, AG, Castro, RQ, Bustamante, J, Perello, C, Ponce, JJU, Serra, HA, Llamoza-Torres, CJ, Montoliu, S, Fernandez-Marcos, C, Guiberteau, A, Vergara, M, Fernandez-Lopez, AM, Gutierrez-Garcia, ML, Hernaez-Alsina, T, Coll, S, Cuyas, B, Morillas, MJ, Olmedo, SR, Fernandez-Bermejo, M, Roget, M, Ramos, IC, Rio, GPD, Rifa, R, Gacho, PC, Barrio, ML, Gomez-Rubio, M, Penas, I, Serra, I, Cachero, A, Reig, M, Giraldez, A, Guerrero, M, Segarra, JX, Lledo, JL, Diaz-Gonzalez, A, Delgado, C, Inarrairaegui, M, Rodriguez-Gonzalez, M, Lazaro, M, Bermudez-Ramos, M, Lue, ALR, Molina, E, Macias-Rodriguez, MA, Rodriguez, M, Chiminazzo, V, Varela, M. Evolving epidemiology of HCC in Spain. Jhep Reports. 2025; 7(5)DOI:10.1016/j.jhepr.2025.101336. PMID:40248605. IF:7.500(Q1/2D).
01/05/2025 Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults
Laue, T, Ballester, MP, Meoli, L, Grabitz, C, Uson, E, D'Antiga, L, McLin, V, Pujadas, M, Carvalho-Gomes, A, Sahuco, I, Bono, A, D'Amico, F, Viganò, R, Diago, E, Lanseros, BT, Inglese, E, Vazquez, DM, Broekhoven, A, Kikkert, M, Morales, SPT, Myeni, SK, Riveiro-Barciela, M, Palom, A, Zeni, N, Brocca, A, Cussigh, A, Cmet, S, Escudero-García, MD, Stocco, M, Natola, LA, Ieluzzi, D, Paon, V, Sangiovanni, A, Farina, E, Dibenedetto, C, Sánchez-Torrijos, Y, Lucena-Varela, A, Román, E, Sánchez, E, Sánchez-Aldehuelo, R, López-Cardona, J, Jeyanesan, D, Morocho, AE, Canas-Perez, I, Eastgate, C, Di Cola, S, Lapenna, L, Zaccherini, G, Bongiovanni, D, Riva, A, Sharma, R, Tsou, HLP, Harris, N, Zanaga, P, Sayaf, K, Hossain, S, Crespo, J, Robles-Diaz, M, Madejón, A, Degroote, H, Korenjak, M, Verhelst, X, García-Samaniego, J, Andrade, RJ, Iruzubieta, P, Wright, G, Caraceni, P, Merli, M, Patel, VC, Gander, A, Albillos, A, Soriano, G, Donato, MF, Sacerdoti, D, Toniutto, P, Buti, M, Duvoux, C, Grossi, PA, Berg, T, Polak, WG, Puoti, M, Bosch-Comas, A, Belli, LS, Burra, P, Russo, FP, Coenraad, M, Calleja, JL, Perricone, G, Chokshi, S, Berenguer, M, Clària, J, Moreau, R, Fernández, J, Arroyo, V, Angeli, P, Sánchez-Garrido, C, Ampuero, J, Piano, S, Nicastro, E, Rock, N, Shawcross, D, Edwards, L, Mutschler, F, Melk, A, Mehta, G, Baumann, U, Jalan, R. Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults. Transplantation Direct. 2025; 11(5)DOI:10.1097/TXD.0000000000001787. PMID:40309027. IF:(Q/D).
01/05/2025 A metagenomics approach to frailty in patients with cirrhosis undergoing a multifactorial intervention
Soriano, G, Vega-Abellaneda, S, Soler, Z, Ortiz, MA, Rossi, G, Roman, E, Laghi, L, Mengucci, C, Cantó, E, Biagini, L, Sanchez, E, Mulet, M, Pons-Tarin, M, Kaur, N, Poca, M, Cuyàs, B, Alvarado-Tapias, E, Vidal, S, Manichanh, C, Escorsell, A. A metagenomics approach to frailty in patients with cirrhosis undergoing a multifactorial intervention. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Generation of patient-derived liver organoids from needle biopsies for precision disease modeling of metabolic-associated steatotic liver disease
Ferrer-Lorente, R, Gomez-Cabeza, D, Buque, X, Arino, S, Segovia-Zafra, A, de la Torre, RAMG, Xu, ZQ, Zanatto, L, Miravet, M, Mercado, M, Rubio, AB, Cervera, M, Jimenez-Massip, A, Alvarado-Tapias, E, Pericas, JM, Graupera, I, Aspichueta, P, Marco-Rius, I, Sancho-Bru, P. Generation of patient-derived liver organoids from needle biopsies for precision disease modeling of metabolic-associated steatotic liver disease. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Plasma exosome antigens as prognostic biomarkers in alcohol-associated hepatitis
Brujats, A, Guinart-Cuadra, A, Osuna-Gomez, R, Canto, E, Poca, M, Roman, E, Fajardo, J, Soriano, G, Villanueva, C, Escorsell, A, Gely, C, Camps, M, Argemi, J, Falcon-Perez, J, Bataller, R, Vidal, S, Alvarado-Tapias, E. Plasma exosome antigens as prognostic biomarkers in alcohol-associated hepatitis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation
Alvarado-Tapias, E, Sayadi, A, Plessier, A, Paradis, V, Michonneau, D, Rautou, PE. Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Impact of physical exercise and protein-enriched nutritional support on the development of post-TIPS hepatic encephalopathy
Baiges, A, Téllez, L, Darnell, A, Borda, D, Alvarado-Tapias, E, Soriano, G, Ferrusquía-Acosta, J, Oña, L, Donate, J, Olavarría, A, Gomez, A, Trabal, J, Costas, A, Sanchez, MM, Lazcano, AL, León, L, Perez, V, Casals, C, Hervas, A, Orts, L, Laxe, S, Closa, C, García-Calderó, H, Madubashetha, H, Turon, F, Hernández-Gea, V, Albillos, A, Garcia-Pagan, JC. Impact of physical exercise and protein-enriched nutritional support on the development of post-TIPS hepatic encephalopathy. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Variables associated with postoperative mortality in advanced chronic liver disease patients undergoing urgent or elective surgery. a multicentre spanish cohort
Canillas, L, Jimenez-Esquivel, N, Amador, A, Brujats, A, Sánchez, J, Pelegrina, A, Pardo, C, Montaña, SH, Camps, M, de Sárraga, C, Vizoso, A, Alvarez, J, Burdio, F, Reverter, E, Carrión, JA. Variables associated with postoperative mortality in advanced chronic liver disease patients undergoing urgent or elective surgery. a multicentre spanish cohort. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Validation of proposed non-invasive criteria for resmetirom treatment in metabolic-associated liver disease in clinical practice
Olveira, A, Crespo, J, Samaniego, LI, Gallego-Durán, R, Panero, JLC, Aller, R, Soria, A, Gómez-Camarero, J, Martin-Mateos, R, Benlloch, S, Pericàs, JM, Morillas, RM, Bernal, V, Diago, M, Turnes, J, Poca, M, Lo Iacono, O, Escudero-García, D, Andrade, RJ, Rosales-Zábal, JM, Jorquera, F, Fernández-Rodríguez, C, Guerra, MH, Romero-Gómez, M, Herrojo, JA. Validation of proposed non-invasive criteria for resmetirom treatment in metabolic-associated liver disease in clinical practice. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Prognostic influence of clinically significant portal hypertension in patients with compensated cirrhosis and hepatocellular carcinoma receiving systemic therapy: The HIPERIA study
Guerrero, A, Verdyguer, MR, Martínez, SM, Campos, M, Sogbe, M, Fajes, JLH, Pascual, S, Cuyas, B, Minguez, B, Lamas-Alvarez, S, Fortea, J, Lopez-Fando, MPV, Lozano, MD, Gómez-Rubio, M, Perelló, C, Gutiérrez, ML, Romero-Gutiérrez, M, Mancebo, A, Planas, JMM, Téllez, L, Panero, JLC, De la Poza, G, Piqueras, B, Puente, A, Varela, M, Genesca, J, Alvarado-Tapias, E, D'Avola, D, Matilla, A, Sangro, B, Reig, M, Lledó, JL, Albillos, A. Prognostic influence of clinically significant portal hypertension in patients with compensated cirrhosis and hepatocellular carcinoma receiving systemic therapy: The HIPERIA study. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Development of portal hypertension after non-cirrhotic non-tumoral recent portal vein thrombosis (RPVT). A long-term follow-up study
Alabau, BB, Plessier, A, Sanchez, FB, Payancé, A, Ballester, TG, Elkrief, L, Sánchez-Lorenzo, A, Larrue, H, Donate, J, Vidal-González, J, Praktiknjo, M, González-Alayón, C, Tripathi, D, Fortea, J, Gioia, S, alvarez-Navascués, C, Raevens, S, Herrera, EL, Protopapas, A, Nery, FGC, Artaza, T, La Mura, V, Baiges, A, Ollivier-Hourmand, I, Darnell, A, Zekrini, K, Belmonte, E, García-Criado, MA, Turon, F, Hernández-Gea, V, Verhelst, X, Riggio, O, Puente, A, Simon-Talero, M, Téllez, L, Bureau, C, Alvarado-Tapias, E, Ballester, MP, Rautou, PE, García-Pagán, JC. Development of portal hypertension after non-cirrhotic non-tumoral recent portal vein thrombosis (RPVT). A long-term follow-up study. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort
Younossi, Z, de Avila, L, Petta, S, Nakajima, A, Crespo, J, Kim, SU, Castera, L, Zheng, MH, Tsochatzis, E, Trivikrama, SK, Shalimar, S, Alswat, KA, Yilmaz, Y, Yu, ML, Francque, S, Chan, WK, Fernández, MIC, Treeprasertsuk, S, Duseja, AK, Gadano, A, Oliveira, CP, Arab, JP, Papatheodoridis, G, Diaz, LA, Sebastiani, G, D'Ambrosio, R, Valsan, A, Khalid, A, Holleboom, AG, El-Kassas, M, Pugliese, N, Singal, AK, Pearlman, B, Choudhary, NS, Cordie, A, Gunn, N, Caussy, C, Mauricio, D, Kawaguchi, T, Russo, FP, Venu, A, Hagström, H, Alkhouri, N, Ananchuensook, P, Mohan, L, Fan, JA, Roberts, S, Wong, VWS, Dunn, W, Ekstedt, M, Goh, GBB, Pessoa, M, Lampertico, P, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapè, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Vessby, J, Xie, CC, Friend, E, Poca, M, Segrestin, B, Arrese, M, Lam, B, Racila, A, Alqahtani, S, Stepanova, M. Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis
Javier, FO, Sánchez, J, Roman, E, Miquel, M, Kaur, N, Ferrusquía-Acosta, J, Poca, M, Solé, C, Cuyàs, B, Casas, M, Alvarado-Tapias, E, Monllor-Nunell, T, Sheila, A, Andreu, F, Brujats, A, Vergara, M, Escorsell, A, Soriano, G. Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder
Ferrusqu a-Acosta, J, Gil-Bello, D, Lampichler, K, Vidal, M, Fuertes, D, Simonis, L, Wu, CJ, Shen, Y, Luo, XF, G mez, FT, Parada-Bl zquez, MJ, Gir ldez-Gallego, A, S nchez-Lorenzo, A, Selva-Tal n, D, Alvarado-Tapias, E, Saltini, D, Squecco, D, Schepis, F, Giudicelli, H, Wagner, M, Thabut, D, Garc a-Calonge, M, Uceda-Andr s, E, Alvarez-Navascu s, C, Koc, O, Miclea, R, Maderuelo, E, Herrera, EL, Casas, M, Miquel, M, Vergara, M, Balcar, L, S nchez, J, Sol , C, Scheiner, B. Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis
Ojeda, A, Magaz, M, Agulleiro, I, Pascual, I, Jimenez-Esquivel, N, Pèlach, A, Cháfer, IT, García-García, S, Maderuelo, E, Puente, A, Cobreros, M, Gonzalez, JV, Amador, A, Alvarado-Tapias, E, Gonzílez-Alayón, C, Téllez, L, Manzano, F, Bernal, V, Lomas, R, Ferrusquía-Acosta, J, Perez, V, Shalaby, S, Baiges, A, Turon, F, Hernández-Gea, V, Romero-Gutiérrez, M, Vives-Moreno, J, Albillos, A, Morant, A, Alonso, JC, Simón-Talero, M, Fortea, J, Herrera, EL, Aguilera, V, Masnou, H, Giráldez-Gallego, A, García-Pagán, JC. Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality
Younossi, Z, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Trivikrama, SK, Mohan, L, Fan, JA, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Khalid, A, Holleboom, AG, Valsan, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapè, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Singal, AK, Diaz, LA, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Lam, B, Racila, A, Alqahtani, S, Stepanova, M. A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
19/04/2025 Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Idalsoaga, F, Diaz, LA, Dunn, W, Mehta, H, Caldentey, V, Arnold, J, Ayares, G, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Khan, MQ, Mortuza, R, Malhi, G, Islam, AH, Guizzetti, L, Ramirez-Cadiz, C, Cabezas, J, Echavarria, V, Poca, M, Cuyas, B, Soriano, G, Cots, MV, Higuera-De La Tijera, MF, Abraldes, JG, Al-Karaghouli, M, Skladany, L, Havaj, DJ, Rincón, D, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study. Egastroenterology. 2025; 3(2)DOI:10.1136/egastro-2024-100179. PMID:40276593. IF:(Q/D).
01/04/2025 Preventing the progression of cirrhosis to decompensation and death
Villanueva, C, Tripathi, D, Bosch, J. Preventing the progression of cirrhosis to decompensation and death. Nature Reviews Gastroenterology & Hepatology. 2025; 22(4)DOI:10.1038/s41575-024-01031-x. PMID:39870944. IF:51.000(Q1/1D).
01/04/2025 Recompensation in Cirrhosis: Biomarkers and Strategies
Ramírez-Quesada, W, Alvarado-Tapias, E, Shalaby, S, Hernández-Gea, V. Recompensation in Cirrhosis: Biomarkers and Strategies. SEMINARS IN LIVER DISEASE. 2025; 45(01)DOI:10.1055/a-2542-9930. PMID:40179966. IF:3.700(Q2/3D).
01/04/2025 Moderate alcohol-associated hepatitis: A real-world multicenter study
Idalsoaga, F, Díaz, LA, Dunn, W, Mehta, H, Muñoz, K, Caldentey, V, Arnold, J, Ayares, G, Mortuza, R, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Ramirez-Cadiz, C, Malhi, G, Ahmed, A, Homsi, H, Abid, Z, Cabezas, J, Echavarría, V, Poca, M, Soriano, G, Cuyas, B, Cots, MV, Higuera-De La Tijera, MF, Ayala-Valverde, M, Perez, D, Gomez, J, Abraldes, JG, Al-Karaghouli, M, Jalal, PK, Ibrahim, MA, García-Tsao, G, Goyes, D, Skladany, L, Havaj, DJ, Sulejova, K, Selcanova, SA, Rincón, D, Chacko, KR, Restrepo, JC, Yaquich, P, Toro, LG, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Moderate alcohol-associated hepatitis: A real-world multicenter study. Hepatology Communications. 2025; 9(4)DOI:10.1097/HC9.0000000000000673. PMID:40131003. IF:4.600(Q1/2D).
11/03/2025 Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial
Pose, E, Jiménez, C, Zaccherini, G, Campion, D, Piano, S, Uschner, FE, de Wit, K, Roux, O, Gananandan, K, Laleman, W, Solé, C, Alonso, S, Cuyàs, B, Ariza, X, Juanola, A, Ma, AT, Napoleone, L, Gratacós-Ginès, J, Tonon, M, Pompili, E, Sánchez-Delgado, J, Allegretti, AS, Morales-Ruiz, M, Carol, M, Pérez-Guasch, M, Fabrellas, N, Pich, J, Martell, C, Joyera, M, Domenech, G, Ríos, J, Torres, F, Serra-Burriel, M, Hernáez, R, Solà, E, Graupera, I, Watson, H, Soriano, G, Bañares, R, Mookerjee, RP, Francoz, C, Beuers, U, Trebicka, J, Angeli, P, Alessandria, C, Caraceni, P, Vargas, VM, Abraldes, JG, Kamath, PS, Ginès, P, LIVERHOPE Consortium. Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025; 333(10)DOI:10.1001/jama.2024.27441. PMID:39908052. IF:55.000(Q1/1D).
01/03/2025 Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide
Beltrans, JS, Guinart-Cuadra, A, Piedras, A, Recios, SM, Mulet, M, Atenza, CZ, Alejandre, J, Joaquíns, AB, Sullivans, IG, Lópezs, JS, Vidal, S, Majems, M. Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025 Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence
Mañosa, M, Oller, B, Garcia-Planella, E, Guardiola, J, Cañete, F, González-Muñoza, C, Camps, B, Calafat, M, Doménech, E. Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. DIGESTIVE AND LIVER DISEASE. 2025; 57(3)DOI:10.1016/j.dld.2024.11.028. PMID:39730282. IF:3.800(Q2/3D).
01/03/2025 Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial
Dajti, E, Villanueva, C, Berzigotti, A, Brujats, A, Albillos, A, Genescà, J, García-Pagán, JC, Colecchia, A, Bosch, J. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial. JOURNAL OF HEPATOLOGY. 2025; 82(3)DOI:10.1016/j.jhep.2024.09.014. PMID:39303875. IF:33.000(Q1/1D).
01/02/2025 Progressive systemic inflammation precedes decompensation in compensated cirrhosis
Sánchez-Aldehuelo, R, Villanueva, C, Genescà, J, García-Pagán, JC, Castillo, E, Calleja, JL, Aracil, C, Bañares, R, Téllez, L, Paule, L, Morillas, RM, Poca, M, Peñas, B, Augustin, S, Abraldes, JG, Alvarado-Tapias, E, Bosch, J, Albillos, A. Progressive systemic inflammation precedes decompensation in compensated cirrhosis. Jhep Reports. 2025; 7(2)DOI:10.1016/j.jhepr.2024.101231. PMID:39850960. IF:7.500(Q1/2D).
01/02/2025 Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU
Mesonero, F, Zabana, Y, Fernández-Clotet, A, Solá, A, Caballol, B, Leo-Carnerero, E, García, MJ, Bertoletti, F, Bastida, G, Suris, G, Casis, B, Ferreiro-Iglesias, R, Calafat, M, Jiménez, I, Miranda-Bautista, J, Lamuela, LJ, Fajardo, I, Torrealba, L, Nájera, R, Sáiz-Chumillas, RM, González-Partida, I, Vicuña, M, García-Morales, N, Gutiérrez, A, López-García, A, Benitez, JM, de Célix, CR, Tejido, C, Brunet, E, Hernandez-Camba, A, Suárez, C, Rodríguez-Lago, I, Piqueras, M, Castaño, A, Ramos, L, Sobrino, A, Rodríguez-Grau, MC, Elosua, A, Montoro, M, Baltar, R, Huguet, JM, Hermida, B, Caballero-Mateos, A, Sánchez-Guillén, L, Bouhmidi, A, Pajares, R, Baston-Rey, I, López-Sanromán, A, Albillos, A, Barreiro-de Acosta, M. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. DIGESTIVE AND LIVER DISEASE. 2025; 57(2)DOI:10.1016/j.dld.2024.09.023. PMID:39455313. IF:3.800(Q2/3D).
01/02/2025 Alcohol-associated liver disease: Natural history, management and novel targeted therapies
Alvarado-Tapias, E, Pose, E, Gratacós-Ginès, J, Clemente-Sánchez, A, López-Pelayo, H, Bataller, R. Alcohol-associated liver disease: Natural history, management and novel targeted therapies. Clinical and Molecular Hepatology. 2025; 31DOI:10.3350/cmh.2024.0709. PMID:39481875. IF:16.900(Q1/1D).
01/02/2025 Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History
Brunet-Mas, E, Selva, A, Bas-Cutrina, F, Brujats, A, Caballol, B, Font, R, Gómez, B, Gonzalez-Muñosa, C, Busquets, D, Monfort, D, Vera, DP, Maristany, E, Cirera, G, Torres, G, Castro-Poceiro, J, Lopez, J, Gonzalez-Gonzalez, L, Márquez-Mosquera, L, Gallach, M, Esteve, M, Tremosa, G, Torra, S, Robles-Alonso, V, Garcia-Iglesias, P, Rodríguez-Lago, I, Calvet, X. Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History. Clinical and Translational Gastroenterology. 2025; 16(2)DOI:10.14309/ctg.0000000000000740. PMID:39729123. IF:3.000(Q2/4D).
22/01/2025 Inter-rater disagreements in applying the Montreal classification for Crohn's disease: The Five-Nations Survey Study
Ukashi, O, Amiot, A, Laharie, D, Menchén, L, Gutierrez, A, Fernandes, S, Pessarelli, T, Correia, F, Gonzalez-Muñoza, C, López-Cardona, J, Acosta, MBD, Yanai, H, Armuzzi, A, Magro, F, Kopylov, U. Inter-rater disagreements in applying the Montreal classification for Crohn's disease: The Five-Nations Survey Study. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0425. PMID:. IF:8.700(Q1/1D).
22/01/2025 Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry
Sard, MC, Mañosa, M, Fernández-Clotet, A, Pasanau, L, Matallana,, Iglesias, E, Hernández-Camba, A, Ucha, P, Nos, P, Barrio, J, Gutiérrez, A, Merino,, Barreiro-de Acosta, M, Cudero, L, Casanova, MJ, González-Muñoza, C, Bujanda, L, Varela, P, Bermejo, F, Torres, N, Mesonero, F, Calvet, X, Rivas, C, Perez, C, Alonso-Abreu,, Rodríguez-Lago,, Vega, P, Zabana, Y, Mora, M, Busquets, D, Rodríguez-Gutiérrez, C, Torres, G, Valldosera, G, Ponferrada, A, Ceballos, D, Pascual, CM, Jiménez, N, Sampedro, M, Irabien, M, Domènech, E, ENEIDA registry, GETECCU. Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0400. PMID:. IF:8.700(Q1/1D).
01/01/2025 Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence
Giordano, A, Pérez-Martínez, I, Gisbert, JP, Ricart, E, Martín-Arranz, MD, Mesonero, F, Parga, MLD, Rivero, M, Iglesias, E, Fernández-Prada, S, Calafat, M, Villarino, MTA, Turrión, MAD, Hernández-Camba, A, Lidón, RV, Carpio, D, Brunet, E, Moranta, FR, García, LA, Cuquerella, JT, Bermejo, F, Madero, L, Esteve, M, González-Muñoza, C, Martínez-Montiel, P, Huguet, JM, Calle, JLP, Rodríguez-Lago, I, Ausín, MS, Poyatos, RHL, García-Bosch, O, Marín, GS, Taxonera, C, Ponferrada-Diaz, A, Barreiro-de Acosta, M, Bujanda, L, Serra, RB, Ramos, L, Vera, I, Abizanda, ES, Piqueras, M, Gómez, CS, García-Sepulcre, MF, Arregui, MV, Murillo, NR, Llaó, J, Lucendo, AJ, Marín-Jiménez, I, Camps-Aler, B, Villafranca, CM, Ceballos, D, Ver, Y, Fernández-Salazar, LI, Alcaín, G, Valldosera, G, Andrés, PR, Martínez-Flores, C, Coronel, AF, Ginard, D, García, L, Gomez, IB, Argueelles-Arias, F, Miyashiro, EI, de la Piscina, PR, Villalba, LH, Notari, PA, Martínez-Pérez, TD, Fernández, H, Gilabert, P, Rosas, CM, Nos, P, Gil, JL, López, VMN, Muñoz, F, Palomares, MTDL, Lucio, AS, Merino, O, de Prado, IN, Leal, C, de Carpi, JM, Sánchez, LB, Arce, NM, Frago, S, Mateu, BB, Domènech, E, Planella, EG. Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(1)DOI:10.14309/ajg.0000000000003207. PMID:39745305. IF:7.600(Q1/1D).